Nervgen Pharma's ROI from its fourth quarter of 2025 to the fourth quarter of and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nervgen Pharma's ROI in the fourth quarter of 2025?
Nervgen Pharma Corp recorded a cumulative net loss of $-34 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -1284.25%.

Within the Healthcare sector Nervgen Pharma Corp achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the third quarter of 2025 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter
Y / Y Investment Change TTM	486.35 %	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	3	3	3	3	2
Return On Investment (TTM)	-1284.25 %	0 %	0 %	0 %	0 %
NGEN's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	7.57 %	37.4 %	59.74 %	148.36 %	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-34	0	0	0	0

NGEN Company Profile >> Back to NGEN Roi Comparisons >> See Annual NGEN Return On Investment

Return On Investment NGEN's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Nervgen Pharma's IV. Quarter Investments	$ 3 Millions	NGEN's Balance sheet
Nervgen Pharma's IV. Quarter Income	$ -34 Millions	Quarterly NGEN's Income Statement
NGEN's Income by Division		See NGEN's Income by Division

NGEN Annual Return On Investment	(Dec 31 2025) 2025
Total Investments in Millions	3	0	0	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-32	0	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-1245.6 %	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NGEN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NGEN's Competitors
Subscribers only: Roi for Nervgen Pharma's Suppliers
Subscribers only: Return On Investment for NGEN's Customers

Other Ratios
NGEN's Roa	NGEN's Inventory Turnover Ratio	NGEN's Growth Rates	NGEN's Dividend Statistics
	NGEN's Profitability Ratios	NGEN's Asset Turnover Ratio	NGEN's Dividend Growth
NGEN's Roe	NGEN's Valuation Ratios	NGEN's Financial Strength Ratios	NGEN's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector

ROI

Date modified: 2026-07-07T12:11:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.